Abstract 1691: Synergistic anti-tumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma

Authors:
  • AMAlexandra Moros
    Alexandra Moros
  • VRVanina Rodriguez
    Vanina Rodriguez
  • ISIfigenia Saborit-Villarroya
    Ifigenia Saborit-Villarroya
  • AMArnau Montraveta
    Arnau Montraveta
  • PBPatricia Balsas
    Patricia Balsas
  • PSPeter Sandy
    Peter Sandy
  • AMAntonio Martinez
    Antonio Martinez
  • ENEmmanuel Normant
    Emmanuel Normant
  • PPPatricia Perez-Galan
    Patricia Perez-Galan
  • ECElias Campo
    Elias Campo
  • DCDolors Colomer
    Dolors Colomer